Treatment of schizoaffective disorder - a challenge for evidence-based psychiatry

被引:22
作者
Jaeger, M. [1 ]
Becker, T.
Weinmann, S. [2 ]
Frasch, K.
机构
[1] Univ Ulm, Dept Psychiat 2, BKH Gunzburg, D-89312 Gunzburg, Germany
[2] Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany
关键词
antipsychotics; mood-stabilizers; classification; schizophrenia; treatment; PSYCHOTIC MOOD DISORDERS; PLACEBO-CONTROLLED TRIAL; LONG-ACTING RISPERIDONE; BIPOLAR DISORDER; DOUBLE-BLIND; CLINICAL PREDICTORS; DECONSTRUCTING PSYCHOSIS; KRAEPELINIAN DICHOTOMY; MAINTENANCE TREATMENT; BEHAVIORAL-DISORDERS;
D O I
10.1111/j.1600-0447.2009.01424.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Schizoaffective disorder is a common diagnosis in mental health services. The aim of the present article was to review treatment studies for schizoaffective disorder and draw conclusions for clinical decision making. Method: We searched MEDLINE and Cochrane Library for relevant clinical trials and review articles up to the year 2008. Results: Thirty-three studies using standardized diagnostic criteria, 14 of which were randomized controlled trials, could be identified. The comparability of studies is limited by the use of different diagnostic criteria. The studies reviewed do not permit consistent recommendations as to whether schizoaffective disorder should be treated primarily with antipsychotics, mood stabilizers or combinations of these drugs. The relevance of diverse subtypes of schizoaffective disorder for treatment recommendations is unclear. Conclusion: The pertinent empirical database is small and heterogeneous. The lack of conclusive recommendations is related to issues of nosological status, plurality of diagnostic criteria and validity of the concept of schizoaffective disorder.
引用
收藏
页码:22 / 32
页数:11
相关论文
共 90 条
  • [1] Deconstructing Psychosis Conference February 2006: The validity of schizophrenia and alternative approaches to the classification of psychosis
    Allardyce, Judith
    Gaebel, Wolfgang
    Zielasek, Jurgen
    van Os, Jim
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (04) : 863 - 867
  • [2] CLASSIFICATION OF SCHIZO-AFFECTIVE PATIENTS BY MULTIDIMENSIONAL-SCALING AND CLUSTER-ANALYSIS
    ANGST, J
    SCHARFETTER, C
    STASSEN, HH
    [J]. PSYCHIATRIA CLINICA, 1983, 16 (2-4): : 254 - 264
  • [3] [Anonymous], 2012, The WHO application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: IDC-MM
  • [4] [Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
  • [5] Prophylaxis of schizoaffective disorder with lithium or carbamazepine:: outcome after long-term follow-up
    Baethge, C
    Gruschka, P
    Berghöfer, A
    Bauer, M
    Müller-Oerlinghausen, B
    Bschor, T
    Smolka, MN
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2004, 79 (1-3) : 43 - 50
  • [6] Long-term treatment of schizoaffective disorder: Review and recommendations
    Baethge, C
    [J]. PHARMACOPSYCHIATRY, 2003, 36 (02) : 45 - 56
  • [7] Basan A., 2004, Cochrane Database Syst. Rev, V1, DOI [DOI 10.1002/14651858.CD004028.PUB2, 10.1002/14651858.CD004028.pub2]
  • [8] Bauer M, 2002, NEUROPSYCHOPHARMACOL, V27, P620
  • [9] BIEDERMAN J, 1979, ARCH GEN PSYCHIAT, V36, P327
  • [10] DISTINCTION BETWEEN THE AFFECTIVE PSYCHOSES AND SCHIZOPHRENIA
    BROCKINGTON, IF
    KENDELL, RE
    WAINWRIGHT, S
    HILLIER, VF
    WALKER, J
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1979, 135 (SEP) : 243 - 248